首页|阿托伐他汀联合复方丹参滴丸治疗冠心病的效果

阿托伐他汀联合复方丹参滴丸治疗冠心病的效果

扫码查看
目的 探讨阿托伐他汀联合复方丹参滴丸治疗冠心病的临床效果。方法 选取三明市第一医院心内科 2021 年 1 月—2023 年 9 月收治的 150 例冠心病患者为研究对象。根据不同治疗药物分为对照组与研究组,各 75 例。对照组行单一方案(阿托伐他汀),研究组行联合方案(阿托伐他汀联合复方丹参滴丸)。比较2组临床疗效、血液流变学变化、氧化应激反应和心功能改善情况。结果 研究组临床总有效率为94。67%(71/75),高于对照组的 80。00%(60/75),差异有统计学意义(P<0。05)。治疗后,研究组全血黏度低切、全血黏度高切、血浆黏度分别为(8。65±0。82)mPa·s、(5。02±0。51)mPa·s、(1。29±0。26)mPa·s,低于对照组的(10。66±0。99)mPa·s、(6。77±0。62)mPa·s、(1。58±0。35)mPa·s,差异有统计学意义(P<0。05)。研究组左室射血分数(left ventricular ejection fractions,LVEF)、6 min内步行距离(6 minute walking distance,6MWD)分别为(66。55±6。05)%、(409。21±41。34)m,高于对照组的(58。83±5。93)%、(386。24±35。42)m,研究组左心室舒张末期内径(left ventricular end diastolic dimension,LVEDD)、左心室收缩末期内径(left ventricular end systolic diameter,LVESD)分别为(50。34±4。74)mm、(46。08±8。24)mm,低于对照组的(55。85±5。48)mm、(49。73±8。65)mm,差异有统计学意义(P<0。05)。研究组超氧化物歧化酶(superoxide dismutase,SOD)、谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-px)分别为(91。84±1。58)Ku/L、(204。75±19。23)U/L,高于对照组的(80。56±1。35)Ku/L、(164。35±17。56)U/L,研究组丙二醛(malondialdehyde,MDA)为(6。02±1。21)μmol/L,低于对照组的(8。89±1。71)μmol/L,差异有统计学意义(P<0。05)。结论 阿托伐他汀联合复方丹参滴丸治疗冠心病可获得明显的效果,不仅可改善血液流变学,还能避免机体长时间处于氧化应激状态,促进心功能恢复,联合用药方案有效性较高。
The Effect of Atorvastatin Combined With Compound Danshen Dropping Pills in the Treatment of Coronary Heart Disease
Objective To explore the clinical effect of atorvastatin combined with Compound Danshen Dropping Pills in the treatment of coronary heart disease.Methods A total of 150 patients with coronary heart disease from the department of cardiology,Sanming First Hospital from January 2021 to September 2023 were selected as the study objects.They were divided into the control group and the research group according to different treatment drugs,75 cases in each group.The control group received a single regimen(atorvastatin),and the research group received combined regimen(atorvastatin combined with Compound Danshen Dropping Pills).The clinical efficacy,changes of hemorheology,oxidative stress response and improvement of cardiac function were compared between the two groups.Results The total clinical effective rate of the research group was 94.67%(71/75),which was higher than 80.00%(60/75)of the control group,the difference was statistically significant(P<0.05).After treatment,whole blood viscosity was low,whole blood viscosity was high,and plasma viscosity of the research group were(8.65±0.82)mPa·s,(5.02±0.51)mPa·s,and(1.29±0.26)mPa·s,which were lower than(10.66±0.99)mPa·s,(6.77±0.62)mPa·s,(1.58±0.35)mPa·s of the control group,and the differences were statistically significant(P<0.05).The left ventricular ejection fractions(LVEF),6 minute walking distance(6MWD)of the research group were(66.55±6.05)%and(409.21±41.34)m,which were higher than(58.83±5.93)%and(386.24±35.42)m of the control group,left ventricular end diastolic dimension(LVEDD),left ventricular end systolic diameter(LVESD)of the research group were(50.34±4.74)mm and(46.08±8.24)mm,which were lower than(55.85±5.48)mm and(49.73±8.65)mm of the control group,the differences were statistically significant(P<0.05).The superoxide dismutase(SOD)and glutathione peroxidase(GSH-px)of the research group were(91.84±1.58)Ku/L and(204.75±19.23)U/L,respectively,which were higher than(80.56±1.35)Ku/L and(164.35±17.56)U/L of the control group,malondialdehyde(MDA)of the research group was(6.02±1.21)μmol/L,which was lower than(8.89±1.71)μmol/L of the control group,and the differences were statistically significant(P<0.05).Conclusion Atorvastatin combined with Compound Danshen Dropping Pills can obtain obvious therapeutic effect in the treatment of coronary heart disease,which can not only improve the hemorheology,but also avoid the body from being in the oxidative stress state for a long time and promote the recovery of cardiac function.The combined drug regimen is highly effective.

atorvastatinCompound Danshen Dropping Pillscoronary heart diseasehemorheologyoxidative stress responsecardiac function

肖志强、张光景

展开 >

三明市第一医院心内科,福建 三明 365000

阿托伐他汀 复方丹参滴丸 冠心病 血液流变学 氧化应激反应 心功能

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(23)